Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in Aligos Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +9 vs. Q4 2023
- Shares held
- 46.2M
- +863.8K (+1.9%) vs. Q4 2023
- Total value
- $45.3M
- +$15.2M (+50.4%) vs. Q4 2023
- New holders
- 11
- 13 more added
- Sold out
- 2
- 6 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 124 | $0 | 0.00% | −317−71.9% | Reduced |
| Qube Research & Technologies Ltd | 2 | $2 | 0.00% | 00.0% | Unchanged |
| ZRC Wealth Management, LLC | 100 | $98 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 298 | $292 | 0.00% | +5+1.7% | Added |
| JPMorgan Chase & Co | 677 | $663 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,104 | $1.00K | 0.00% | +1,104 | New |
| Morgan Stanley | 3,300 | $3.23K | 0.00% | +1,300+65.0% | Added |
| Tower Research Capital LLC (TRC) | 8,022 | $7.86K | 0.00% | −10,706−57.2% | Reduced |
| Financial Advocates Investment Management | 10,000 | $9.80K | 0.00% | +10,000 | New |
| Total Clarity Wealth Management, Inc. | 10,000 | $9.80K | 0.00% | +10,000 | New |
| UBS Group AG | 10,825 | $10.6K | 0.00% | +10,825 | New |
| Vontobel Holding Ltd. | 12,500 | $12.3K | 0.00% | +12,500 | New |
| Zullo Investment Group, Inc. | 13,000 | $12.7K | 0.01% | 00.0% | Unchanged |
| ZWJ Investment Counsel Inc | 14,500 | $14.2K | 0.00% | +14,500 | New |
| Creative Planning | 15,525 | $15.2K | 0.00% | +5,475+54.5% | Added |
| CWM, LLC | 16,891 | $17.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 18,624 | $18.3K | 0.00% | 00.0% | Unchanged |
| HarbourVest Partners LLC | 18,783 | $18.4K | 0.01% | 00.0% | Unchanged |
| Procyon Private Wealth Partners, LLC | 20,000 | $19.6K | 0.00% | +20,000 | New |
| Choate Investment Advisors | 24,000 | $23.5K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 31,383 | $30.8K | 0.00% | 00.0% | Unchanged |
| Atom Investors LP | 34,173 | $33.5K | 0.00% | +34,173 | New |
| XTX Topco Ltd | 44,871 | $44.0K | 0.01% | +19,128+74.3% | Added |
| Bridgeway Capital Management, LLC | 92,000 | $90.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 92,015 | $90.2K | 0.00% | +38,047+70.5% | Added |
| State Street Corp | 97,423 | $95.5K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 110,661 | $108.4K | 0.00% | +81,956+285.5% | Added |
| Citadel Advisors LLC | 285,679 | $280.0K | 0.00% | +285,679 | New |
| BlackRock Inc. | 303,755 | $297.7K | 0.00% | +7,616+2.6% | Added |
| Geode Capital Management, LLC | 373,056 | $365.7K | 0.00% | +52,012+16.2% | Added |
| UBS Oconnor LLC | 500,000 | $490.0K | 0.01% | +500,000 | New |
| Silverarc Capital Management, LLC | 655,515 | $642.4K | 0.18% | −12,997−1.9% | Reduced |
| Acadian Asset Management LLC | 657,995 | $644.0K | 0.00% | +98,628+17.6% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $728.4K | 0.47% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 808,260 | $792.0K | 0.00% | +318,300+65.0% | Added |
| Vanguard Group Inc | 1,013,067 | $992.8K | 0.00% | +1,416+0.1% | Added |
| Bank of America Corp | 1,147,727 | $1.12M | 0.00% | −350.0% | Reduced |
| Newtyn Management, LLC | 1,200,000 | $1.18M | 0.23% | −55,000−4.4% | Reduced |
| Opaleye Management Inc. | 1,630,000 | $1.60M | 0.35% | +333,000+25.7% | Added |
| Tang Capital Management LLC | 1,650,000 | $1.62M | 0.17% | −539,847−24.7% | Reduced |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,906,191 | $1.87M | 0.04% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,076,400 | $2.03M | 0.03% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 2,320,381 | $2.27M | 2.20% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 2,464,505 | $2.42M | 0.00% | +2,464,505 | New |
| Altitude Crest Partners Inc. | 2,844,681 | $2.79M | 1.19% | 00.0% | Unchanged |
| Vivo Capital, LLC | 3,547,030 | $3.48M | 0.27% | 00.0% | Unchanged |
| Deep Track Capital, LP | 6,102,770 | $5.98M | 0.17% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 6,389,468 | $6.26M | 0.16% | 00.0% | Unchanged |
| Armistice Capital, LLC | 6,893,410 | $6.76M | 0.18% | +59,535+0.9% | Added |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −2,882,216−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,739−100.0% | Sold out |